# Serial Measurement of Pancreatic Stone Protein (PSP) for Sepsis Early Detection in ICU Patients

> **NCT07232784** · — · COMPLETED · sponsor: **Fapon Biotech Inc.** · enrollment: 250 (actual)

## Conditions studied

- Adult Patients at High Risk of Sepsis

## Interventions

- **DEVICE:** blood sampling

## Key facts

- **NCT ID:** NCT07232784
- **Lead sponsor:** Fapon Biotech Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-10
- **Primary completion:** 2025-02-07
- **Final completion:** 2025-03-31
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2025-11-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07232784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07232784, "Serial Measurement of Pancreatic Stone Protein (PSP) for Sepsis Early Detection in ICU Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07232784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*